ロード中...
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
INTRODUCTION: Achieving functional cure of chronic HBV infection (Hepatitis B surface antigen [HBsAg] clearance, eventually followed by acquisition of anti-hepatitis B surface antigen [Anti-HBs]) in individuals with HIV and HBV infections is a rare event. In this setting, factors related to HBV cure...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6472771/ https://ncbi.nlm.nih.gov/pubmed/30998789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0215464 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|